DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...
A recent investigation by Hunterbrook alleged that Dexcom "dropped the ball" in ensuring the accuracy and reliability of its G7 glucose monitoring device. Some patients reportedly experienced severe ...
The analyst says DexCom can expand the market through increased coverage and reclaim recent market share losses. William Blair foresees significant growth potential in intensive insulin users. See the ...
At least three digital health companies are poised to take advantage of native Bluetooth on the Apple Watch, announced at the company’s WWDC keynote last month. In addition to Dexcom (which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback